StemCyte

StemCyte, as a leading brand in the clinical application of stem cells, not only preserves umbilical cord blood to the highest standards but also actively invests in the research and development of stem cells. Using umbilical cord blood from its public donation bank, StemCyte participates in numerous clinical trials for various diseases. StemCyte has an absolute leading advantage in regenerative medicine applications and remains committed to doing what truly benefits society. StemCyte is advancing disease treatment applications globally, including in the United States, China, and Taiwan, with several ongoing clinical trials related to stem cells, such as "spinal cord injury," "acute and chronic stroke," and "HIV/AIDS." The goal is to expand the use of stem cells into broader medical fields, aspiring to solve diseases that currently lack effective treatments under the philosophy of "Better Cell, Better Life" to improve human life.